S-Space

Browse

Title

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sort by
In order
Results/Page
Authors/record

Showing results 3,041 to 3,060 of 4,461

Issue Date	Title / Author(s) / Citation	File
2018-11	Phase Ib/II study of capmatinib (INC280) plus gefitinib after failure of epidermal growth factor receptor (EGFR) inhibitor therapy in patients with EGFR-mutated, MET factor-dysregulated non-small-cell lung cancer Wu, Yi-Long; Zhang, Li; Kim, Dong-Wan; Liu, Xiaoqing; Lee, Dae Ho; Yang, James Chih-Hsin; Ahn, Myung-Ju; Vansteenkiste, Johan F.; Su, Wu-Chou; Felip, Enriqueta; Chia, Vincent; Glaser, Sabine; Pultar, Philippe; Zhao, Sylvia; Peng, Bin; Akimov, Mikhail; Tan, Daniel S. W. Journal of Clinical Oncology, Vol.36 No.31, pp.3101-3109	DOI
2018-09	Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer Cho, Byoung Chul; Dy, Grace K.; Govindan, Ramaswamy; Kim, Dong-Wan; Pennell, Nathan A.; Zalcman, Gerard; Besse, Benjamin; Kim, Joo-Hang; Koca, Goekben; Rajagopalan, Prabhu; Langer, Simon; Ocker, Matthias; Nogai, Hendrik; Barlesi, Fabrice Lung Cancer, Vol.123, pp.14-21	DOI
2012-09	Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer Kim, Jae-Sung; Lim, Joo Han; Kim, Jee Hyun; Im, Seock-Ah; Chie, Eui Kyu; Hwang, Jin-Hyeok; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung Whan; Yoon, Yong Bum Cancer Chemotherapy and Pharmacology, Vol.70 No.3, pp.381-389	DOI
1999-10	Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma Kim, Noe Kyeong; Im, Seock-Ah; Kim, Dong-Wam; Lee, Moon H.; Jung, Chul W.; Cho, Eun K.; Lee, Jong T.; Ahn, Jin S.; Heo, Dae S.; Bang, Yung-Jue Cancer, Vol.86 No.7, pp.1109-1115	DOI
2008-06	Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer Lee, Hyo-Pyo; Seo, Sang-Soo; Ryu, Sang-Young; Kim, Jong-Hyeok; Bang, Yung-Jue; Park, Sang-Yoon; Nam, Joo-Hyun; Kang, Soon-Beorn; Lee, Kyung-Hee; Song, Yong Sang Gynecologic Oncology, Vol.109 No.3, pp.359-363	DOI
2009-01	Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer Han, S-W; Oh, D-Y; Im, S-A; Park, S. R.; Lee, K-W; Song, H. S.; Lee, N-S; Lee, K. H.; Choi, I. S.; Lee, M. H.; Kim, M. A.; Kim, W. H.; Bang, Y-J; Kim, T-Y British Journal of Cancer, Vol.100 No.2, pp.298-304	DOI
2024-04	Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations Hong, David S.; Cappuzzo, Federico; Chul Cho, Byoung; Dowlati, Afshin; Hussein, Maen; Kim, Dong-Wan; Percent, Ivor; Christensen, James G.; Morin, Josée; Potvin, Diane; Faltaos, Demiana; Tassell, Vanessa; Der-Torossian, Hirak; Chao, Richard Lung Cancer, Vol.190, p. 107512	DOI
2021-02	Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib Lee, Dae-Won; Cho, Eun Ju; Lee, Jeong-Hoon; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Tae-Yong; Han, Sae-Won; Oh, Do Youn; Im, Seock-Ah; Kim, Tae-You; Lee, Youngeun; Kim, Haeryoung; Lee, Kyung-Hun Clinical Cancer Research, Vol.27 No.3, pp.713-718	DOI
2007-07	Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea-Japan collaborative study group trial Kim, Yeul Hong; Yamaguchi, Kensei; Bang, Yung-Jue; Takiuchi, Hiroya; Kang, Won Ki; Sato, Atsushi; Kang, Yoon-Koo; Sakamoto, Junichi; Abe, Chigusa; Sakata, Yuh Japanese Journal of Clinical Oncology, Vol.37 No.7, pp.501-508	DOI
2011-06	Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis Hong, Junshik; Han, Sae-Won; Ham, Hye Seon; Kim, Tae-Yong; Choi, In Sil; Kim, Byung-Su; Oh, Do-Youn; Im, Seock-Ah; Kang, Gyeong Hoon; Bang, Yung-Jue; Kim, Tae-You Cancer Chemotherapy and Pharmacology, Vol.67 No.6, pp.1323-1331	DOI
2018-05	Phase II study of crizotinib in east asian patients with ROS1-positive advanced non–small-cell lung cancer Wu, Yi-Long; Yang, James Chih-Hsin; Kim, Dong-Wan; Lu, Shun; Zhou, Jianying; Seto, Takashi; Yang, Jin-Ji; Yamamoto, Noboru; Ahn, Myung-Ju; Takahashi, Toshiaki; Yamanaka, Takeharu; Kemner, Allison; Roychowdhury, Debasish; Paolini, Jolanda; Usari, Tiziana; Wilner, Keith D.; Goto, Koichi Journal of Clinical Oncology, Vol.36 No.14, pp.1405-1411	DOI
2020-12	Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07 Kim, Miso; Keam, Bhumsuk; Ock, Chan-Young; Kim, Se Hyun; Kim, Yu Jung; Lim, Sun Min; Kim, Jin-Soo; Kim, Tae Min; Hong, Sook-Hee; Ahn, Mi Sun; Shin, Seong Hoon; Kang, Eun Joo; Kim, Dong-Wan; Im, Sun-Wha; Kim, Jong-Il; Lee, Jong Seok; Kim, Joo-Hang; Heo, Dae Seog Thoracic Cancer, Vol.11 No.12, pp.3482-3489	DOI
2017-04	Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer Kim, Miso; Keam, Bhumsuk; Kim, Tae-Min; Kim, Hoon-Gu; Kim, Jin-Soo; Lee, Sung Sook; Shin, Seong Hoon; Kim, Min Kyoung; Park, Keon Uk; Kim, Dong-Wan; Yun, Hwan Jung; Lee, Jong Seok; Heo, Dae Seog Cancer Research and Treatment, Vol.49 No.2, pp.416-422	view file DOI
2007-09	Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer Lee, Keun-Wook; Kim, Jee Hyun; Yun, Tak; Song, Eun Kee; Na, Im Il; Shin, Hytinchoon; Oh, So Yeon; Choi, In Sil; Oh, Do-Youn; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Journal of Korean Medical Science, Vol.22, pp.S115-S121	view file
2017-06	Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach Kurokawa, Yukinori; Yang, Han-Kwang; Cho, Haruhiko; Ryu, Min-Hee; Masuzawa, Toru; Park, Sook Ryun; Matsumoto, Sohei; Lee, Hyuk-Joon; Honda, Hiroshi; Kwon, Oh Kyoung; Ishikawa, Takashi; Lee, Kyung Hee; Nabeshima, Kazuhito; Kong, Seong-Ho; Shimokawa, Toshio; Yook, Jeong-Hwan; Doki, Yuichiro; Im, Seock-Ah; Hirota, Seiichi; Hahn, Seokyung; Nishida, Toshirou; Kang, Yoon-Koo British Journal of Cancer, Vol.117 No.1, pp.25-32	DOI
2003-03	Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer Kim, DY; Kim, JH; Lee, SH; Kim, TY; Heo, DS; Bang, YJ; Kim, NK Annals of Oncology, Vol.14 No.3, pp.383-387	DOI
2011-12	Phase II study of sunitinib as second-line treatment for advanced gastric cancer Bang, Yung-Jue; Kang, Yoon-Koo; Kang, Won K.; Boku, Narikazu; Chung, Hyun C.; Chen, Jen-Shi; Doi, Toshihiko; Sun, Yan; Shen, Lin; Qin, Shukui; Ng, Wai-Tong; Tursi, Jennifer M.; Lechuga, Maria J.; Lu, Dongrui Ray; Ruiz-Garcia, Ana; Sobrero, Alberto Investigational New Drugs, Vol.29 No.6, pp.1449-1458	DOI
2016-10	Phase II trial of dacomitinib in patients with HER2-positive gastric cancer Oh, Do-Youn; Lee, Kewn-Wook; Cho, Jae Yong; Kang, Won Ki; Im, Seock-Ah; Kim, Jin Won; Bang, Yung-Jue Gastric Cancer, Vol.19 No.4, pp.1095-1103	DOI
2014-09	Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer Lee, Keun-Wook; Kim, Yu Jung; Lee, Kyung-Hun; Han, Sae-Won; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Choi, In Sil; Kim, Jee Hyun Cancer Chemotherapy and Pharmacology, Vol.74 No.3, pp.447-455	DOI
2005-12	Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer Lee, Keun-Wook; Im, Seock Ah; Yun, Tak; Song, Eun Kee; Na, Im Il; Shin, Hyunchoon; Choi, In Sil; Oh, Do Youn; Kim, Jee Hyun; Kim, Dong Wan; Kim, Tae You; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.35 No.12, pp.720-726	DOI

1 150 151 152 153 154 155 156 224